ePS06.4 Patient-specific modeling of regional tobramycin concentration levels in airways of patients with cystic fibrosis: can we dose once daily?
Bos, A.C, van Holsbeke, C, de Backer, J.W, Janssens, H.M, Vos, W.G, Tiddens, H.A.W.M
Published in Journal of cystic fibrosis (01.06.2016)
Published in Journal of cystic fibrosis (01.06.2016)
Get full text
Journal Article
WS13.5 Pharmacokinetics and safety of once daily double dose inhaled tobramycin administered with the controlled-inhalation AKITA® and conventional PARI-LC® Plus nebulizer in cystic fibrosis
van Velzen, A.J, Bos, A.C, Touw, D.J, Tiddens, H.A.W.M, Heijerman, H.G.M, Janssens, H.M
Published in Journal of cystic fibrosis (01.06.2015)
Published in Journal of cystic fibrosis (01.06.2015)
Get full text
Journal Article
Bordetella species in children with cystic fibrosis: What do we know?
Bos, A.C, Beemsterboer, P, Wolfs, T.F.W, Versteegh, F.G.A, Arets, H.G.M
Published in Journal of cystic fibrosis (2011)
Published in Journal of cystic fibrosis (2011)
Get full text
Journal Article
Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization
van Velzen, A J, Bos, A C, Touw, D J, Tiddens, H A W M, Heijerman, H G M, Janssens, H M
Published in Journal of aerosol medicine (01.06.2016)
Published in Journal of aerosol medicine (01.06.2016)
Get full text
Journal Article